3 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 35141743 | Number Needed to Treat and Cost Per Responder of Janus Kinase Inhibitors Approved for the Treatment of Moderate-to-Severe Rheumatoid Arthritis in Japan. | 2022 Feb 10 | 1 |
2 | 35142908 | Relative remission rates of Janus kinase inhibitors in comparison with adalimumab in patients with active rheumatoid arthritis: a network meta-analysis. | 2022 Feb 10 | 1 |
3 | 33053283 | Trial of Upadacitinib or Abatacept in Rheumatoid Arthritis. | 2020 Oct 15 | 1 |